Robis, Thessa Faye E.
HRN: 21-76-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2022
AMPICILLIN 1GM (VIAL)
08/17/2022
08/24/2022
IVT
2g As LD Then 1g
Q6
PROM
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes